← All trials
NCT05203172
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 5, 2022
- Primary completion
- May 3, 2027
- Completion date
- May 3, 2027
- First posted
- Jan 24, 2022
- Last posted
- Dec 16, 2022
- Enrollment
- 46
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.